Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
On-demand provision criteria for iPS cells in mitochondrial disease
jRCT1030250200Recruiting
- Start
- Jul 2025
- Countries
- 1
01
Overview
Open-label, single-arm trial of induced pluripotent stem cells in Mitochondriopathy, sponsored by none. Primary endpoints: Expression of pluripotency markers, Proliferative capacity and 4 more. Started Jul 2025; status: recruiting.
02
Drugs
induced pluripotent stem cells
03
Conditions
Mitochondriopathy
Beyond the preview
Go deeper on jRCT1030250200.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1030250200.